InvestorsObserver
×
News Home

Is Cyclo Therapeutics Inc (CYTH) a Winner in the Healthcare Sector?

Wednesday, November 22, 2023 01:01 PM | InvestorsObserver Analysts

Mentioned in this article

Is Cyclo Therapeutics Inc (CYTH) a Winner in the Healthcare Sector?

A rating of 71 puts Cyclo Therapeutics Inc (CYTH) near the top of the Healthcare sector according to InvestorsObserver. Cyclo Therapeutics Inc's score of 71 means that it ranks higher than 71% of stocks in the sector. In addition, its overall score of 38 ranks it higher than 38% of all stocks.

Overall Score - 38
CYTH has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on CYTH!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 38 would rank higher than 38 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Cyclo Therapeutics Inc Stock Today?

Cyclo Therapeutics Inc (CYTH) stock has fallen -3.23% while the S&P 500 has gained 0.41% as of 12:30 PM on Wednesday, Nov 22. CYTH is down -$0.04 from the previous closing price of $1.24 on volume of 50,879 shares. Over the past year the S&P 500 has risen 13.82% while CYTH has gained 26.32%. CYTH lost -$1.88 per share the over the last 12 months. Click Here to get the full Stock Report for Cyclo Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App